A 19 year old male complain of dry cough in night, cough increases in lying down position no cough in day, no complain of fever, bodyache, on examination in lung inspiratory wheeze are heard on bilateral chest oscaltation, s1s2 heard spo 2 96 pulse 88/min whats provisional diagnosis and further step and treatment
Reading File
Finding Sources
Finding Sources
Searching PubMed
nocturnal cough variant asthma diagnosis treatment
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have enough information for a comprehensive answer. Let me compile it.
Provisional Diagnosis: Cough-Variant Asthma (Nocturnal Asthma)
Why This Fits
| Clinical Feature | Significance |
|---|---|
| 19-year-old male | Peak age for atopic/allergic asthma onset |
| Dry cough, exclusively at night | Classic nocturnal asthma pattern |
| Cough worsens lying down | Supine posture increases vagal tone, reduces lung volumes, increases airway secretions pooling |
| No cough during the day | Typical of cough-variant asthma - cough may be the sole presenting symptom in up to 57% of asthmatics |
| Bilateral inspiratory wheeze | Airflow limitation due to bronchospasm |
| No fever, no body ache | Argues strongly against infective causes (viral URTI, pneumonia) |
| SpO2 96%, HR 88 - clinically stable | Mild/intermittent disease, not a severe exacerbation |
"Asthma may present predominantly with cough, often nocturnal, and the diagnosis is supported by the presence of reversible airflow limitation, bronchial hyperresponsiveness... Cough as the only presenting symptom of asthma has been reported in up to 57% of patients and is often its most prominent symptom."
- Murray & Nadel's Textbook of Respiratory Medicine
Differential Diagnoses to Exclude
- GERD (Gastroesophageal Reflux Disease) - nocturnal, positional cough due to microaspiration; no wheeze typically
- Upper Airway Cough Syndrome / Post-nasal drip - nocturnal cough, but usually "cobblestone" pharynx, nasal symptoms
- Eosinophilic bronchitis - chronic cough, sputum eosinophilia, but NO bronchial hyperresponsiveness
- Vocal cord dysfunction - inspiratory stridor pattern, not true wheeze
- Cardiac asthma (heart failure) - excluded: no orthopnea, no edema, S1/S2 normal, age 19 is atypical
Further Investigations (Step-Up)
First Line (Outpatient)
| Investigation | Purpose |
|---|---|
| Spirometry (pre- and post-bronchodilator) | Shows obstructive pattern (FEV1/FVC < 0.7); >12% and >200 mL improvement after salbutamol confirms reversibility - hallmark of asthma |
| Peak Expiratory Flow Rate (PEFR) monitoring | Serial morning and evening PEFR; >20% diurnal variation strongly suggests asthma |
| Methacholine/Histamine bronchial provocation test | If spirometry is normal - confirms bronchial hyperresponsiveness |
| Chest X-ray (PA view) | Rule out TB, pneumonia, hyperinflation; likely normal in asthma |
| CBC with differential | Peripheral eosinophilia supports atopic/allergic etiology |
| Total serum IgE + Skin prick tests / RAST | Identify allergen sensitization (house dust mite, pollen, etc.) |
| FeNO (Fractional exhaled Nitric Oxide) | Elevated (>25 ppb) indicates eosinophilic airway inflammation |
If Diagnosis Still Uncertain
- CT chest (rule out structural causes, bronchiectasis)
- 24-hour ambulatory pH monitoring (if GERD suspected)
- ENT evaluation (postnasal drip)
Treatment
This patient has mild intermittent to mild persistent asthma (GINA Step 1-2).
Step 1 - Immediate Reliever (PRN)
- Salbutamol (Albuterol) MDI 100 mcg - 2 puffs as needed for symptoms
- Onset: 3-5 minutes, duration: 4-6 hours
- Teach correct inhaler technique and use of spacer
Step 2 - Controller Therapy (Start Given Nocturnal Symptoms)
- Inhaled Corticosteroid (ICS): Low-dose ICS is the preferred step-2 controller
- e.g., Budesonide 200 mcg twice daily OR Beclomethasone 100 mcg twice daily
- Reduces airway inflammation, prevents nocturnal exacerbations
- Alternative: Low-dose ICS/formoterol combination as both reliever and controller (GINA 2024 "MART" strategy)
- LTRA (Leukotriene receptor antagonist): Montelukast 10 mg at night - alternative for those who cannot use inhaler
Adjunctive Measures
- Allergen avoidance: Identify and reduce triggers (dust mites, pet dander, cockroaches, tobacco smoke)
- Pillow and mattress covers (if dust mite allergy)
- Sleep position: Slightly elevated head (reduces supine-related airway changes)
- Avoid NSAIDs/aspirin until aspirin-exacerbated respiratory disease is excluded
Follow-Up Protocol
- Review in 4-6 weeks - reassess symptom control, inhaler technique, adherence
- Step up therapy if symptoms not controlled; Step down after 3 months of good control
- Provide a written Asthma Action Plan
Summary Table
| Domain | Recommendation |
|---|---|
| Provisional Dx | Cough-variant / Nocturnal Asthma |
| Key Investigation | Spirometry with reversibility test |
| Reliever | Salbutamol MDI 2 puffs PRN |
| Controller | Low-dose ICS (Budesonide 200 mcg BD) |
| Trigger control | Allergen avoidance, no smoking |
| Review | 4-6 weeks |
This patient is stable (SpO2 96%, not in distress) and can be managed in the outpatient setting. If spirometry confirms reversible airflow obstruction, the diagnosis of asthma is confirmed and step-therapy can be titrated accordingly.
Sources: Harrison's Principles of Internal Medicine 22E; Murray & Nadel's Textbook of Respiratory Medicine (GINA-based step therapy)
This is a shared conversation. Sign in to Orris to start your own chat.